Royal Bank of Canada’s KraneShares Emerging Markets Healthcare Index ETF KMED Stock Holding History

Royal Bank of Canada’s Portfolio KMED Stock Details KMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-44	Closed	-$1K	–	7867
2023 Q1	$1K	Hold	44	–	–	﹤0.01%	6983
2022 Q4	$1K	Hold	44	–	–	﹤0.01%	7133
2022 Q3	$1K	Sell	44 -4	-8%	-$87	﹤0.01%	7342
2022 Q2	$1K	Hold	48	–	–	﹤0.01%	7268
2022 Q1	$1K	Hold	48	–	–	﹤0.01%	7653
2021 Q4	$1K	Hold	48	–	–	﹤0.01%	7577
2021 Q3	$1K	Hold	48	–	–	﹤0.01%	7536
2021 Q2	$2K	Hold	48	–	–	﹤0.01%	7277
2021 Q1	$2K	Hold	48	–	–	﹤0.01%	7265
2020 Q4	$2K	Buy	+48	New	+$1.56K	﹤0.01%	6891

Other funds holding KMED

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada's KMED Position: Q2 2023 in Review

Royal Bank of Canada sold out of KraneShares Emerging Markets Healthcare Index ETF (KMED) in Q2 2023, closing a stake of 44 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in KMED in Q4 2020 and held it in 10 quarters. The position peaked at $2K in Q2 2021. 2 funds tracked by Wall St. Rank hold KMED as of Q2 2023.

Royal Bank of Canada reported no remaining KraneShares Emerging Markets Healthcare Index ETF position as of Q2 2023 after selling out during the quarter.
Royal Bank of Canada sold 44 KraneShares Emerging Markets Healthcare Index ETF shares in Q2 2023, an estimated $1K.
Royal Bank of Canada first reported a position in KraneShares Emerging Markets Healthcare Index ETF in Q4 2020 and held it in 10 quarters.
Royal Bank of Canada's KraneShares Emerging Markets Healthcare Index ETF position peaked at $2K in Q2 2021.
2 funds tracked by Wall St. Rank held KraneShares Emerging Markets Healthcare Index ETF as of Q2 2023.

Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.